Fourth study published over two-year span that analyzes key leukemia protein
Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies published over the last two years in the journal Cell, and the final paper published Dec. 20 in Genes & Development.
When a key protein responsible for leukemia, MLL, is stabilized, it slows the progression of the leukemia, the most recent study found. The next step will be to combine the treatments from the past two years of research into a pediatric leukemia “super drug” to test on humans in a clinical trial.
The survival rate is only 30 percent for children diagnosed with MLL-translocation leukemia, a cancer that affects the blood and bone marrow. Patients with leukemia have a very low percentage of red blood cells, making them anemic, and have approximately 80 times more white blood cells than people without cancer.
30%Current survival rate for pediatric leukemia patients.
“These white blood cells infiltrate many of the tissues and organs of the affected individuals and is a major cause of death in leukemia patients,” said senior author Ali Shilatifard, the Robert Francis Furchgott Professor of Biochemistry and Molecular Genetics and Pediatrics, the chairman of biochemistry and molecular genetics and the director of Northwestern’s Simpson Querrey Center for Epigenetics. “This is a monster cancer that we’ve been dealing with for many years in children.”
There are several types of leukemia. This research focused on the two most common found in infants through teenagers: acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL).
For the past 25 years, Shilatifard’s laboratory has been studying the molecular function of MLL within its complex known as COMPASS (Complex Proteins Associated with Set1). Most recently, it was demonstrated that COMPASS components are one of the most frequently identified mutations in cancer.The next step of this work will be to bring the drug to a clinical trial setting, which Shilatifard said he hopes will happen in the next three to five years.
“I’ve been working on this translocation for more than two decades, and we’re finally at the point where in five to 10 years, we can get a drug in kids that can be effective,” Shilatifard said. “If we can bring that survival rate up to 85 percent, that’s a major accomplishment.”
Earlier work from Shilatifard’s laboratory published in Cell in 2018 identified compounds that could slow cancer growth by interrupting a gene transcription process known as “Super Elongation Complex” (SEC). It was the first compound in its class to do this.
This MLL stabilization process discovered in the most recent paper could potentially work in cancers with solid tumors, such as breast or prostate cancer, said first author Zibo Zhao, a postdoctoral research fellow in Shilatifard’s lab.
“This opens up a new therapeutic approach not only for leukemia, which is so important for the many children who are diagnosed with this terrible cancer, but also for other types of cancers that plague the population,” Zhao said.
“The publication of these four papers and the possibility of a future human clinical trial could not have happened if it weren’t for the cross-disciplinary collaboration at Northwestern,” Shilatifard said.
The Latest on: Pediatric leukemia
via Google News
The Latest on: Pediatric leukemia
- Cloud doodles help charities after artist's daughter diagnosed with leukemiaon November 23, 2020 at 12:21 am
Aoibheann's Pink Tie and Childhood Cancer Foundation. Their three-year-old daughter Juno is undergoing treatment for leukemia since her diagnosis in January of this year. Chris Judge posts a daily ...
- Blood platelet supply critically low at Children’s Hospital Colorado, more donors neededon November 22, 2020 at 6:41 pm
Blood and platelets literally kept Will Maniatis alive while he was in treatment. He spent months at Children’s Hospital Colorado fighting acute myeloid leukemia. His mother Claudia Maniatis said ...
- Leukemia Therapeutics Market Size, Trends, Outlook, Opportunity Till 2028on November 20, 2020 at 12:36 pm
Research Nester has released a report titled “ Leukemia Therapeutics Market – Global Demand Analysis & Opportunity Outlook 2028” which also includes some of the prominent market analyzing parameters ...
- Phoenix girl with leukemia becomes a princess for a day with 'wish'on November 18, 2020 at 9:06 am
Wish Arizona make the wish to become a princess for one day come true for the 6-year-old transforming her from head-to-toe.
- Meta-Analysis: Living Near Petrochemical Facilities Raises Risk of Leukemiaon November 18, 2020 at 4:04 am
The risk of leukemia is higher for people living near petroleum industry complexes, according to a new analysis of 13 studies of the issue.
- Grandmother With Aggressive Leukemia Needs Help. Are You the Miracle Match?on November 17, 2020 at 10:26 am
The race is on to save a 60-year-old grandmother diagnosed with an aggressive form of leukemia who needs a match for a blood stem cell transplant to survive. Maria Banuelos’ children and grandchildren ...
- Disney, Make-A-Wish turn 6-year-old Latina with leukemia into princess with help from Spanish-speaking Belleon November 12, 2020 at 10:17 am
With a huge smile that will brighten anyone’s 2020, María, a young Latina who lives in Arizona, fulfilled her dream of becoming a princess for a day. There may be many negative things happening in the ...
- Yemen children with leukemia in dire need of medical supplieson November 12, 2020 at 1:45 am
Life for Yemeni children with blood cancer is cruel amid scarcity of medical staff, medicines, and equipment due to war and blockade in the country. SANAA, Nov. 12 (Xinhua) -- Abeer Sadeq, ...
- The Leukemia & Lymphoma Society and Rally Foundation for Childhood Cancer Research Announce Collaboration to Fight Pediatric Leukemiaon November 10, 2020 at 5:00 am
PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and Rally Foundation for Childhood Cancer Research (Rally) announced today that they are teaming up ...
- Leukemia Therapeutics Market- Development Status, Emerging Trends, Revenue Growth, Development And Demand Forecast To 2028on November 9, 2020 at 8:41 am
Research Nester has released a report titled " Leukemia Therapeutics Market - Global Demand Analysis & Opportunity Outlook 2028" which also includes some of the prominent market analyzing parameters ...
via Bing News